Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharina Gerhards

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Viruses|February 28, 2023
Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-SyndromeCatharina Gerhards, Maximilian Kittel, Volker Ast, et al.
Clinical Laboratory|December 15, 2021
SARS-CoV-2 Antibody Testing - How to Increase the Positive Predictive ValueMargot Thiaucourt, Catharina Gerhards, Maximilian Kittel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2020
Clinical evaluation of commercial automated SARS-CoV-2 immunoassaysMaximilian Kittel, Maria Christina Muth, Ingrid Zahn, et al.
Microorganisms|July 29, 2023
Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 PatientsCatharina Gerhards, Verena Haselmann, Samuel F Schaible, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2020
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testingVerena Haselmann, Mustafa K Özçürümez, Frank Klawonn, et al.
Journal of Clinical Microbiology|June 30, 2021
Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody DetectionVolker Ast, Victor Costina, Romy Eichner, et al.
JCO Clinical Cancer Informatics|December 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical DataJonathan Bobak, Philipp Spohr, Sarah Richter, et al.
Frontiers in Immunology|October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Frontiers in Cellular and Infection Microbiology|January 23, 2026
Molecular characterization of cell decay in inflammation and topological assignment of released cfDNA for integrative laboratory and radiological outcome assessmentCatharina Gerhards, Stefanie Nittka, Volker Ast, et al.
Annals of Hematology|May 21, 2022
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseasesJil Rotterdam, Margot Thiaucourt, Christel Weiss, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Viruses|February 28, 2023
Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-SyndromeCatharina Gerhards, Maximilian Kittel, Volker Ast, et al.
Clinical Laboratory|December 15, 2021
SARS-CoV-2 Antibody Testing - How to Increase the Positive Predictive ValueMargot Thiaucourt, Catharina Gerhards, Maximilian Kittel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2020
Clinical evaluation of commercial automated SARS-CoV-2 immunoassaysMaximilian Kittel, Maria Christina Muth, Ingrid Zahn, et al.
Microorganisms|July 29, 2023
Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 PatientsCatharina Gerhards, Verena Haselmann, Samuel F Schaible, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2020
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testingVerena Haselmann, Mustafa K Özçürümez, Frank Klawonn, et al.
Journal of Clinical Microbiology|June 30, 2021
Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody DetectionVolker Ast, Victor Costina, Romy Eichner, et al.
JCO Clinical Cancer Informatics|December 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical DataJonathan Bobak, Philipp Spohr, Sarah Richter, et al.
Frontiers in Immunology|October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Frontiers in Cellular and Infection Microbiology|January 23, 2026
Molecular characterization of cell decay in inflammation and topological assignment of released cfDNA for integrative laboratory and radiological outcome assessmentCatharina Gerhards, Stefanie Nittka, Volker Ast, et al.
Annals of Hematology|May 21, 2022
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseasesJil Rotterdam, Margot Thiaucourt, Christel Weiss, et al.
Pageof 2